BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi GN, Dias ICDS, Baker G, Bouso Saiz JC, Dursun SM, Hallak JEC, Dos Santos RG. Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability. Expert Opin Drug Saf 2022. [PMID: 35301934 DOI: 10.1080/14740338.2022.2054988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Berlowitz I, García Torres E, Maake C, Wolf U, Martin-Soelch C. Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study. Plants (Basel) 2023;12. [PMID: 36679060 DOI: 10.3390/plants12020346] [Reference Citation Analysis]
2 Maia LO, Daldegan-Bueno D, Wießner I, Araujo DB, Tófoli LF. Ayahuasca's therapeutic potential: What we know - and what not. Eur Neuropsychopharmacol 2023;66:45-61. [PMID: 36368095 DOI: 10.1016/j.euroneuro.2022.10.008] [Reference Citation Analysis]
3 Rossi GN, Guerra LTL, Baker GB, Dursun SM, Saiz JCB, Hallak JEC, dos Santos RG. Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant. Biomolecules 2022;12:1618. [DOI: 10.3390/biom12111618] [Reference Citation Analysis]
4 Simonsson O, Bouso JC, Kurth F, Araújo DB, Gaser C, Riba J, Luders E. Preliminary evidence of links between ayahuasca use and the corpus callosum. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.1002455] [Reference Citation Analysis]